Affymetrix Showcases Third-Party Microarray Analysis Software Like it or not, biologists have to deal increasingly in informatics as their experiments generate ever larger and more complex data sets.

Offerings Now Encompass Multiplex and Parallel Analysis of Cells, Proteins, and Genes Affymetrix, best known for its pioneering work in commercializing microarrays for gene expression research since ...

Genomatix Software GmbH today announced that it has achieved GeneChip-compatible TM status for several products with the Affymetrix Inc. (Nasdaq: AFFX) GeneChip® microarray platform and that it has ...

Following the Silicon Valley pattern of jamming more power into less space, Santa Clara's Affymetrix will disclose today that it has packed most of the human genome onto two DNA chips. Previously, ...

OXFORD, England--(BUSINESS WIRE)--Cytox Ltd, an innovative developer of assays for risk assessment and prediction of dementia, and Affymetrix (Nasdaq:AFFX), a leading provider of translational ...

Combination of the mTOR inhibitor Rapamycin and HSP90 inhibitor 17-allylamino-17-demethoxygeldanamycin (17AAG) inhibits proliferation and induces apoptosis in multiple myeloma (MM) A major obstacle in ...